Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningGraft SurvivalAnemia, AplasticLeukemiaTransplantation ChimeraKidney TransplantationHistocompatibility TestingBusulfanBone Marrow PurgingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicCyclophosphamideGraft RejectionBone Marrow DiseasesMice, Inbred C57BLCombined Modality TherapyRecurrenceTime FactorsTreatment OutcomeHematopoiesisRadiation ChimeraHeart TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteHematologic NeoplasmsTransplantation ImmunologyLiving DonorsBone Marrow ExaminationImmunosuppressionImmunosuppressive AgentsRemission InductionRetrospective StudiesSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseGraft vs Host ReactionBone RemodelingBone Marrow NeoplasmsLymphocyte DepletionLeukocyte TransfusionLeukemia, MyeloidLung TransplantationStem Cell TransplantationAcute DiseaseT-LymphocytesLymphoma, Non-HodgkinHLA AntigensOrgan TransplantationAntineoplastic Combined Chemotherapy ProtocolsChimeraCyclosporineFollow-Up StudiesSurvival RateColony-Forming Units AssaySevere Combined ImmunodeficiencyMice, Inbred BALB CFlow CytometryMyelodysplastic SyndromesBreast NeoplasmsLymphocyte TransfusionActuarial AnalysisBlood DonorsHematologic DiseasesCytomegalovirus InfectionsCell DifferentiationCell ProliferationBone DensityDisease-Free SurvivalAntineoplastic AgentsPrognosisNuclear FamilyNeoplasmsSpleenTransplantationGraft vs Tumor EffectCarmustineCells, CulturedLeukocyte CountPancytopeniaApoptosisGraft vs Leukemia EffectEtoposideAntibodies, MonoclonalGranulocyte Colony-Stimulating FactorCytarabineTransplantation, HeterologousCell Line, TumorLymphoma